Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 101-110 of 146

Page
per page
  1. Entrectinib
    B5859 Entrectinib
    Target: Trk Receptors|ALK|ROS1
    Summary: Orally active inhibitor of ALK kinase
      ≥28.05 mg/mL
  2. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: Novel autophagy inhibitor
      insoluble in H2O; ≥13.5 mg/mL
  3. RI-2
    B5881 RI-2
    Target: RAD51
    Summary: Optimized reversible RAD51 inhibitor
      ≥21.65 mg/mL
  4. CCT251545
    B5979 CCT251545
    Summary: Orally bioavailable and potent WNT signaling inhibitor
      ≥42.2 mg/mL
  5. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  6. LDC000067
    B4754 LDC000067
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor, novel and highly specific
      insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
  7. HTH-01-015
    A8890 HTH-01-015
    Target: NUAK
    Summary: NUAK1 inhibitor,highly specific and selective
      ≥23.45 mg/mL
  8. p-Cresyl sulfate
    A8895 p-Cresyl sulfate
     2 Citation
    Summary: Protein-bound uremic retention solute
      insoluble in EtOH; ≥30.1 mg/mL
  9. Necrosulfonamide
    B7731 Necrosulfonamide
     1 Citation
    Target: Mixed lineage kinase domain-like protein (MLKL)
    Summary: Necroptosis inhibitor
      ≥46.1 mg/mL
  10. DLPC
    B7661 DLPC
    Target: Nuclear Receptors
    Summary: LRH-1 agonist ligand
      ≥26.9 mg/mL

Items 101-110 of 146

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 12item
  2. Apoptosis 9item
  3. Chromatin/Epigenetics 10item
  4. Metabolism 9item
  5. MAPK Signaling 10item
  6. Tyrosine Kinase 23item
  7. DNA Damage/DNA Repair 10item
  8. PI3K/Akt/mTOR Signaling 12item
  9. Microbiology & Virology 7item
  10. Cell Cycle/Checkpoint 10item
  11. Ubiquitination/ Proteasome 11item
  12. JAK/STAT Signaling 3item
  13. TGF-β / Smad Signaling 2item
  14. Angiogenesis 1 item
  15. GPCR/G protein 12item
  16. Stem Cell 3item
  17. Membrane Transporter/Ion Channel 5item
  18. Endocrinology and Hormones 3item
  19. Neuroscience 6item
  20. Others 10item
  21. Immunology/Inflammation 2item
Reversibility
  1. Reversible 9item
  2. Irreversible 5item
Target
  1. Caspases 3item
  2. Cyclin-Dependent Kinases 6item
  3. Proteasome 4item
  4. Cathepsins 2item
  5. Histone Deacetylases (HDACs) 5item
  6. PI3K 6item
  7. CXCR 1 item
  8. Raf 4item
  9. CSF-1R 1 item
  10. EZH2 1 item
  11. mTOR 1 item
  12. MMP 1 item
  13. Peptidylprolyl isomerases 1 item
  14. FLT3 2item
  15. GSK-3 2item
  16. Factor Xa 1 item
  17. LPA Receptors 1 item
  18. VEGFR 6item
  19. PDGFR 5item
  20. c-Kit 2item
  21. RET 1 item
  22. p38 2item
  23. 3-phosphoglycerate dehydrogenase 1 item
  24. JNK 3item
  25. MEK 1 item
  26. FGFR 3item
  27. Liver X receptors (LXRs) 1 item
  28. Deubiquitinating enzymes (DUBs) 2item
  29. PP1 1 item
  30. PP2A 1 item
  31. Eukaryotic elongation factors 1 item
  32. Ribosomal s6 kinases (RSK) 1 item
  33. Neuraminidases (NA) 1 item
  34. MET 3item
  35. Trk Receptors 3item
  36. STAT 1 item
  37. Microtubules/Tubulins 2item
  38. Estrogen and Related Receptors 2item
  39. EGFR 1 item
  40. ROCK 2item
  41. BTK 1 item
  42. RIP kinases 1 item
  43. JAK 1 item
  44. EZH1 1 item
  45. HSP90 1 item
  46. Angiotensin AT2 Receptors 1 item
  47. Topoisomerases 2item
  48. Cytochrome P450 (CYP450) 1 item
  49. M3 Receptors 1 item
  50. S6 kinases 1 item
  51. Toll-like receptors (TLRs) 1 item
  52. Adenosine Kinases 1 item
  53. Actin 1 item
  54. Epac 1 item
  55. Survivin 1 item
  56. ERK 1 item
  57. HMG-CoA Reductases 1 item
  58. Vacuolar-type ATPase 1 item
  59. c-MET 3item
  60. PKC 1 item
  61. Calpains 1 item
  62. Ubiquitin-specific proteases 1 item
  63. RAD51 1 item
  64. Trypsins 1 item
  65. HER2 2item
  66. 5-HT2 Receptors 1 item
  67. DGAT 1 item
  68. Insulin and Insulin-like Receptors 1 item
  69. PARP 1 item
  70. ALK 2item
  71. ROS1 1 item
  72. NK1 Receptors 1 item
  73. Dehydrogenase 1 item
  74. PKG 1 item
  75. PKA 1 item
  76. Myosin light chain kinases (MLCKs) 2item
  77. HIV-1 gp120 1 item
  78. D2 Receptors 1 item
  79. Pancreatic and duodenal homeobox 1 (PDX1) 1 item
  80. Autophagy 1 item
  81. Mixed lineage kinase domain-like protein (MLKL) 1 item
  82. COX 1 item
  83. IDH2 1 item
  84. Ron 1 item
  85. Synthases/Synthetases 1 item
  86. TAK1 1 item
  87. Histamine H1 Receptors 1 item
  88. Phospholipases 1 item
  89. IL Receptors 1 item
  90. CCL2 1 item
  91. Proton Pump 1 item
  92. cAMP 1 item
  93. Sulfonylurea receptors 1 item
  94. Peptidoglycan synthesis 1 item
  95. Nuclear Receptors 1 item
  96. Catechol O-Methyltransferase (COMT) 1 item
  97. Angiotensin AT1 Receptors 1 item
  98. DREADD Ligands 1 item
  99. PP4 1 item
  100. Ub-conjugating enzyme (E2) complex 1 item
  101. PPAR 1 item
  102. IKK 1 item
  103. P97 ATPase 1 item
  104. ITK 1 item
  105. NUAK 1 item
  106. NOP Receptors 1 item
  107. PRMT 1 item
  108. Serotonin (5-HT) reuptake 1 item
  109. NE 1 item
  110. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 122item
  2. Cell Experiments 75item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 2item
  5. B-lymphoid Malignancies 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 21item
  8. Cancer 71item
  9. Chronic Lymphocytic Leukemia 2item
  10. Cocaine-Related Disorders 1 item
  11. Colon Cancer 6item
  12. Colorectal Cancer 11item
  13. Depression 1 item
  14. Diabetes 2item
  15. Glioblastoma 7item
  16. Glioma 5item
  17. Hepatocellular Carcinoma 2item
  18. HIV 1 item
  19. Inflammatory Diseases 1 item
  20. Leukemia 1 item
  21. Lung Cancer 4item
  22. Lung Carcinoma 2item
  23. Lymphoma 6item
  24. Mantle Cell Lymphoma 2item
  25. Melanoma 7item
  26. Multiple Myeloma 5item
  27. Myeloma 2item
  28. Neuroblastoma 4item
  29. Neurocognitive Disorders 1 item
  30. Non-small Cell Lung Cancer 5item
  31. Obsessive-Compulsive Disorder 1 item
  32. Osteoporosis 1 item
  33. Ovarian Cancer 6item
  34. Pancreatic Cancer 8item
  35. Prostate Cancer 7item
  36. Renal Cancer 1 item
  37. Renal Cell Carcinoma 2item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 1 item
  40. Thyroid Cancer 1 item
  41. Type 2 Diabetes 2item